Suppliers / Inventaa Industries

Inventaa Industries

India Updated 9 July 2026

Inventaa Industries is an API manufacturer based in India. It holds one active US drug master file. Its most recent recorded inspection, by US FDA, closed on 28 June 2018 as NAI. Customs aggregates show $1.6M of exports covering 20 molecules to 8 destinations in 2025.

1
active US DMFs
0
valid CEPs
1
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
2 of 2 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 28 June 2018 NAI US FDA
  • 8 April 2016 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
India, India 3003903069

What they file, and where

Molecule Regulators Docs
Trimethoprim US FDA 1

Also appears on these molecule pages

Trimethoprim API

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $612K 3
2025 Not reported $1.6M 8
2024 Not reported $1.5M 9
2023 Not reported $2.7M 8

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about Inventaa Industries

Does Inventaa Industries hold a US DMF or a CEP?
Inventaa Industries holds 1 active US drug master file. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Inventaa Industries FDA-registered?
One site operated by Inventaa Industries carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Inventaa Industries's last inspection go?
The most recent inspection on record closed on 28 June 2018 as NAI (No Action Indicated: nothing objectionable was found). 2 inspections are on file.
Where does Inventaa Industries manufacture?
1 registered site is on record, in India (India). Every site is listed on this page with the register it came from.
What does Inventaa Industries make?
1 molecule is on record against Inventaa Industries, including Trimethoprim. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Inventaa Industries comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was NAI, on 28 June 2018.

Comparable suppliers

Ipca Laboratories shares 1 molecule Shandong Xinhua Pharmaceutical shares 1 molecule Shouguang Fukang Pharmaceutical shares 1 molecule Southwest Synthetic Pharmaceutical shares 1 molecule Andhra Organics shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
Customs aggregates
Export values, molecule and destination counts